🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a longitudinal, one arm, prospective phase II study, designed to ev...
Status
Completed
Location
IBCC Oncologia
Start Date
2020-12-17
Trial ID
NCT04669132
Treatments Being Tested
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
The purpose of this study is to determine that panitumumab will have clinic...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT00083616
Treatments Being Tested
The main purpose of this study is to determine the threshold level of lower...
Status
Completed
Location
Abbott Northwestern Hospital
Start Date
2022-01-03
Trial ID
NCT05330104
Treatments Being Tested
The CHIP-AML22 Master protocol has the overall aim of increasing the cure r...
Status
Recruiting
Location
Princess Máxima Center for pediatric oncology
Start Date
2024-02-06
Trial ID
NCT06262438
The current trial is evaluating the impact of deep regional hyperthermia on...
Status
Completed
Location
University Hospital Tübingen, Department of Radiation Oncology
Start Date
2012-08
Trial ID
NCT02353858
Treatments Being Tested
This is an open-label, multicenter, Phase 1a study to evaluate the safety, ...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2021-09-07
Trial ID
NCT04975958
Treatments Being Tested
ARQ 197 or placebo in combination with irinotecan and cetuximab in particip...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-26
Trial ID
NCT01075048
Treatments Being Tested
Research purpose: Degree of continuous intravenous pumping Endostar (human...
Status
Unknown
Location
Jiangsu Taizhou People's Hospital
Start Date
2015-02
Trial ID
NCT02513355
Treatments Being Tested
RATIONALE: Pioglitazone may slow the growth of tumor cells and may be an ef...
Status
Terminated
Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Start Date
2009-03-02
Trial ID
NCT00867126